SCHEMBL13007285

SCHEMBL13007285

Cn1ccc2cc(CO)c(OCI)cc2c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 6/20 0.38
TP53 P04637 4/20 0.37
MAPT P10636 3/20 0.37
PDE5A O76074 1/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 2/20 0.34
BRD9 Q9H8M2 2/20 0.33
MTNR1A P48039 1/20 0.33
MTNR1B P49286 1/20 0.33
CDK4 P11802 1/20 0.33
CCND1 P24385 1/20 0.33
PSMB1 P20618 1/20 0.33
PSMB2 P49721 1/20 0.33
BRD4 O60885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13007287 0.94 TNF (0.38) TNFTP53MAPTPDE5APDE4A
SCHEMBL14106255 0.80 TNF (0.47) TNFTP53MAPTPDE5APDE4A
SCHEMBL13007276 0.80 TNF (0.40) TNFTP53MAPTBRD9CDK4
SCHEMBL13007272 0.77 TNF (0.40) TNFTP53MAPTBRD9CDK4
SCHEMBL13007286 0.75 LMNA (0.41) TP53MAPTLMNAPOLBBRD9
SCHEMBL16328854 0.72 TNF (0.53) TNFMAPTLMNAPOLBMTNR1A
SCHEMBL13007333 0.72 TNF (0.46) TNFMAPTPDE3BPDE3ALMNA
SCHEMBL23946136 0.71 TNF (0.46) TNFMAPTLMNAMTNR1AMTNR1B
SCHEMBL3768022 0.71 TNF (0.46) TNFMAPTLMNAPOLB
SCHEMBL14149433 0.69 TNF (0.48) TNFTP53MAPTLMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100317691-A1 ISOQUINOLONE COMPOUNDS AS SUBTYPE-SELECTIVE AGONISTS FOR MELATONIN RECEPTORS MT1 AND MT2 THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317691-A1 ISOQUINOLONE COMPOUNDS AS SUBTYPE-SELECTIVE AGONISTS FOR MELATONIN RECEPTORS MT1 AND MT2 MTNR1A, MTNR1B, MC2R TNF 3844/4885TP53 3413/4885MAPT 3085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.